Dosimetry characterization of $^{32}$P intravascular brachytherapy source wires using Monte Carlo codes PENELOPE and GEANT4

Javier Torres,Manuel J. Buades,Julio F. Almansa,Rafael Guerrero,Antonio M. Lallena
DOI: https://doi.org/10.1118/1.1637970
2003-11-22
Abstract:Monte Carlo calculations using the codes PENELOPE and GEANT4 have been performed to characterize the dosimetric parameters of the new 20 mm long catheter based $^{32}$P beta source manufactured by Guidant Corporation. The dose distribution along the transverse axis and the two dimensional dose rate table have been calculated. Also, the dose rate at the reference point, the radial dose function and the anisotropy function were evaluated according to the adapted TG-60 formalism for cylindrical sources. PENELOPE and GEANT4 codes were first verified against previous results corresponding to the old 27 mm Guidant $^{32}$P beta source. The dose rate at the reference point for the unsheathed 27 mm source in water was calculated to be $0.215 \pm 0.001$ cGy s$^{-1}$ mCi$^{-1}$, for PENELOPE, and $0.2312 \pm 0.0008$ cGy s$^{-1}$ mCi$^{-1}$, for GEANT4. For the unsheathed 20 mm source these values were $0.2908 \pm 0.0009$ cGy s$^{-1}$ mCi$^{-1}$ and $0.311 \pm 0.001$ cGy s$^{-1}$ mCi$^{-1}$, respectively. Also, a comparison with the limited data available on this new source is shown. We found non negligible differences between the results obtained with PENELOPE and GEANT4.
Medical Physics
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to perform dosimetric characterization of the new 20 - millimeter - long 32P endovascular brachytherapy source manufactured by Guidant through the use of Monte Carlo simulation codes PENELOPE and GEANT4. Specifically, the authors hope: 1. **Verify the accuracy of Monte Carlo simulation codes**: By simulating the old 27 - millimeter 32P source and comparing the results with existing experimental data and the results of other Monte Carlo codes, to ensure the reliability of PENELOPE and GEANT4 when simulating the new 20 - millimeter source. 2. **Determine the dose distribution of the new 20 - millimeter source**: Calculate the dose distribution along the transverse axis, the two - dimensional dose - rate table, as well as the dose - rate at the reference point, the radial dose function and the anisotropy function. These parameters are crucial for evaluating the application of 32P sources in endovascular brachytherapy. 3. **Evaluate the differences between different Monte Carlo codes**: By comparing the simulation results of PENELOPE and GEANT4, explore the differences between the two in the simulation of low - energy electron transport, especially their performance when dealing with complex geometries (such as sources in blood vessels). ### Specific problem decomposition - **Dose - rate calculation**: The authors calculated the reference - point dose - rates of the unencapsulated 20 - millimeter source in water, which are 0.2908 ± 0.0009 cGy s⁻¹mCi⁻¹ (PENELOPE) and 0.311 ± 0.001 cGy s⁻¹mCi⁻¹ (GEANT4) respectively, and compared them with the results of the old 27 - millimeter source. - **Dose - distribution analysis**: The dose distributions along the transverse and axial axes were obtained through simulation, and the results were compared with other Monte Carlo codes in the literature (such as MCNPv4B2, EGSnrc, etc.). It was found that there are certain differences between different codes, especially at larger ρ values. - **Radial dose function and anisotropy function**: According to the adapted version of the TG - 60 official specification, the radial dose function and the anisotropy function were calculated to further evaluate the dosimetric characteristics of the source. ### Important formula The radial dose function \(g(\rho)\) is defined as follows: \[g(\rho)=\frac{\dot{D}(\rho, z_0)}{\dot{D}(\rho_0, z_0)}\cdot\frac{G(\rho_0, z_0)}{G(\rho, z_0)}\] where \(\dot{D}(\rho, z_0)\) is the dose - rate at the radial distance \(\rho\) and the axial position \(z_0\), and \(G(\rho, z_0)\) is the corresponding geometric factor. Through these studies, the authors aim to provide reliable dosimetric data for clinical applications, thereby optimizing the effect of 32P endovascular brachytherapy and reducing the incidence of restenosis.